Osteoarthritis, Knee — Comparison of CoCr Alloy and TiN Coating in TKA
Citation(s)
Fabry C, Zietz C, Baumann A, Ehall R, Bader R High wear resistance of femoral components coated with titanium nitride: a retrieval analysis. Knee Surg Sports Traumatol Arthrosc. 2018 Sep;26(9):2630-2639. doi: 10.1007/s00167-017-4578-7. Epub 2017 May 20.
Fennema P, Heyse TJ, Uyl-de Groot CA Cost-effectiveness and clinical implications of advanced bearings in total knee arthroplasty: a long-term modeling analysis. Int J Technol Assess Health Care. 2014 Apr;30(2):218-25. doi: 10.1017/S0266462314000129. Epub 2014 Apr 28.
Gudnason A, Hailer NP, W-Dahl A, Sundberg M, Robertsson O All-Polyethylene Versus Metal-Backed Tibial Components-An Analysis of 27,733 Cruciate-Retaining Total Knee Replacements from the Swedish Knee Arthroplasty Register. J Bone Joint Surg Am. 2014 Jun 18;96(12):994-999. doi: 10.2106/JBJS.M.00373.
Lapaj L, Wendland J, Markuszewski J, Mroz A, Wisniewski T Retrieval analysis of titanium nitride (TiN) coated prosthetic femoral heads articulating with polyethylene. J Mech Behav Biomed Mater. 2015 Mar;55:127-139. doi: 10.1016/j.jmbbm.2015.10.012. Epub 2015 Oct 30.
Paxton EW, Inacio MC, Kurtz S, Love R, Cafri G, Namba RS Is there a difference in total knee arthroplasty risk of revision in highly crosslinked versus conventional polyethylene? Clin Orthop Relat Res. 2015 Mar;473(3):999-1008. doi: 10.1007/s11999-014-4046-3.
Postler A, Beyer F, Lutzner C, Tille E, Lutzner J Similar outcome during short-term follow-up after coated and uncoated total knee arthroplasty: a randomized controlled study. Knee Surg Sports Traumatol Arthrosc. 2018 Nov;26(11):3459-3467. doi: 10.1007/s00167-018-4928-0. Epub 2018 Apr 3.
Comparison of Cobalt-Chromium (CoCr) Alloy and Titanium-Nitride (TiN) Coating in Total Knee Arthroplasty: A Prospective, Randomised, Double-blinded Clinical Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
